Evidence map›Paper›PMID 19193845›Full record

ArticleJournal of clinical microbiology2009

Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature.

Shawn R Lockhart, Shawn A Messer, Michael Gherna, Justin A Bishop, William G Merz, Michael A Pfaller, Daniel J Diekema

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Review
  2. The journal of venomous animals and toxins including tropical diseases · 2026
    Article
  3. An update on clinically relevant, rare, and emergingClinical microbiology reviews · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. A Review of Studies onAdvanced biomedical research · 2022
    Review
  8. Candidiasis byJournal of fungi (Basel, Switzerland) · 2021
    Article
  9. Candida bracarensis, an emerging yeast involved in human infections.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2021
    Article
  10. First Isolation of Candida nivariensis, an Emerging Fungal Pathogen, in Kuwait.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2021
    Article
  11. Article
  12. Article
  13. Identification of Cryptic Species of FourJournal of fungi (Basel, Switzerland) · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shawn R LockhartUniversity of Iowa, Carver College of Medicine, Iowa City, Iowa 52242, USA.
Shawn A Messer
Michael Gherna
Justin A Bishop
William G Merz
Michael A Pfaller
Daniel J Diekema

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We analyzed 1,598 Candida glabrata isolates for the presence of the cryptic species Candida nivariensis and Candida bracarensis. Both species were very rare in this collection (0.2% prevalence), despite the number of isolates analyzed and the global distribution of the isolates. We saw no associated antifungal resistance in C. nivariensis.

Indexed as

CandidaCandidiasisDNA, FungalDrug Resistance, FungalHumansMicrobial Sensitivity TestsPolymerase Chain ReactionPrevalenceDNA, Fungal

Identifiers

PMID19193845
PMCPMC2668319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.